4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tianda Pharmaceuticals Limited (0455) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 573 employees. Its market capitalization is roughly HK$254 million. In the fiscal year ended 2025-12-31, 0455 reported HK$323M in revenue and (HK$70M) in net income.
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
Interactive charts & full statements → Open the 0455 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue | HK$323M | HK$330M | HK$532M | HK$510M |
| Gross Profit | HK$133M | HK$152M | HK$256M | HK$241M |
| Operating Income (EBIT) | (HK$52M) | (HK$50M) | (HK$24M) | (HK$42M) |
| Net Income | (HK$70M) | (HK$61M) | (HK$24M) | (HK$20M) |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-03-31 |
|---|---|---|---|---|
| Dividends Paid | — | (HK$6M) | (HK$6M) | (HK$9M) |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | HK$748M | HK$765M | HK$917M | HK$1.1B | — |
| Total Liabilities | HK$292M | HK$259M | HK$325M | HK$434M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0455 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms